Psychosis induced by amphetamines

Current Opinion in Psychiatry

Volumn 29, Issue 4, 2016, Pages 236-241

  Bramness, Jørgen G ^a,d   Rognli, Eline B ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders   (Norway)

^d Institute of Clinical Medicine   (Norway)

Author keywords

amphetamine; drug treatment; methamphetamine; neurobiology; psychosis

Indexed keywords

AMPHETAMINE DERIVATIVE;

AGITATION; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; GABAERGIC SYSTEM; HUMAN; NEUROBIOLOGY; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE USE; AMPHETAMINE DEPENDENCE; COMPLICATION; PSYCHOSES, SUBSTANCE-INDUCED;

AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; HUMANS; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 84967327779     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000254     Document Type: Review

References (42)

1. Harro J. Neuropsychiatric adverse effects of amphetamine and methamphetamine. Int Rev Neurobiol 2015; 120:179-204.
2. Sanchez-Ramos J. Neurologic complications of psychomotor stimulant abuse. Int Rev Neurobiol 2015; 120:131-160.
3. Rognli EB, Bramness JG. Understanding the relationship between amphetamines and psychosis. Curr Addict Rep 2015; 2:285-292.
4. Degenhardt L, Coffey C, Hearps S, et al. Associations between psychotic symptoms and substance use in young offenders. Drug Alcohol Rev 2015; 34:673-682.
5. Gilder DA, Gizer IR, Lau P, Ehlers CL. Stimulant dependence and stimulant associated psychosis: clinical characteristics and age of onset in a native American community sample. J Addict Med 2014; 8:241-248.
6. Rognli EB, Hakansson A, Berge J, Bramness JG. Does the pattern of amphetamine use prior to incarceration predict later psychosis?: a longitudinal study of amphetamine users in the Swedish criminal justice system. Drug Alcohol Depend 2014; 143:219-224.
7. Ding Y, Lin H, Zhou L, et al. Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis. Drug Alcohol Depend 2014; 142:295-300.
8. Bramness JG, Gundersen OH, Guterstam J, et al. Amphetamine-induced psychosis: a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry 2012; 12:221.
9. Stefanis NC, Dragovic M, Power BD, et al. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort. Schizophr Res 2014; 156:211-216.
10. Moran LV, Masters GA, Pingali S, et al. Prescription stimulant use is associated with earlier onset of psychosis. J Psychiatr Res 2015; 71:41-47.
11. Marwaha S, Thompson A, Bebbington P, et al. Adult attention deficit hyperactivity symptoms and psychosis: epidemiological evidence from a population survey in England. Psychiatry Res 2015; 229:49-56.
12. van der Meer FJ, Meijer JH, Meijer CJ, et al. Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls. Psychol Med 2014; 44:1901-1911.
13. Fassbender C, Lesh TA, Ursu S, Salo R. Reaction time variability and related brain activity in methamphetamine psychosis. Biol Psychiatry 2015; 77:465-474.
14. Chen CK, Lin SK, Chen YC, et al. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users. Drug Alcohol Depend 2015; 148:158-164.
15. Ezzatpanah Z, Shariat SV, Tehrani-Doost M. Cognitive functions in methamphetamine induced psychosis compared to schizophrenia and normal subjects. Iran J Psychiatry 2014; 9:152-157.
16. Sara GE, Burgess PM, Malhi GS, et al. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample. Aust N Z J Psychiatry 2014; 48:1036-1047.
17. Sara GE, Large MM, Matheson SL, et al. Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation. Aust N Z J Psychiatry 2015; 49:106-117.
18. Hussein RA, Elsheshtawy E, Hafiz AH. Rate of substance use among patients with first-episode psychosis. Middle East Curr Psychiatry 2015; 22:203-207.
19. Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs 2014; 28:1115-1126.
20. Ghaffari-Nejad A, Ziaadini H, Saffari-Zadeha S, et al. A study of the phenomenology of psychosis induced by methamphetamine: a preliminary research. Addict Health 2014; 6:105-111.
21. Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: a systematic review from the most populated Persian Gulf country. Asian J Psychiatry 2015; 16:17-25.
22. Okada N, Takahashi K, Nishimura Y, et al. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multichannel near-infrared spectroscopy study. Addict Biol 2015; 21:489-503.
23. Yamamuro K, Makinodan M, Kimoto S, et al. Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine induced psychosis and schizophrenia. Sci Rep 2015; 5:12107.
24. Hides L, Dawe S, McKetin R, et al. Primary and substance-induced psychotic disorders in methamphetamine users. Psychiatry Res 2015; 226:91-96.
25. Medhus S, Rognli EB, Gossop M, et al. Amphetamine-induced psychosis: transition to schizophrenia and mortality in a small prospective sample. Am J Addict 2015; 24:586-589.
26. Wearne TA, Mirzaei M, Franklin JL, et al. Methamphetamine-induced sensitization is associated with alterations to the proteome of the prefrontal cortex: implications for the maintenance of psychotic disorders. J Proteome Res 2015; 14:397-410.
27. Jiao D, Liu Y, Li X, et al. The role of the GABA system in amphetamine-type stimulant use disorders. Front Cell Neurosci 2015; 9:162.
28. Ahn KH, Sewell A, Elander J, et al. Role of GABA deficit in sensitivity to the psychotomimetic effects of amphetamine. Neuropsychopharmacology 2015; 40:2822-2831.
29. Hsieh JH, Stein DJ, Howells FM. The neurobiology of methamphetamine induced psychosis. Front Human Neurosci 2014; 8:537.
30. Larsen KE, Fon EA, Hastings TG, et al. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci 2002; 22:8951-8960.
31. Espelin DE, Done AK. Chlorpromazine vs. amphetamine. N Engl J Med 1968; 279:329.
32. Espelin DE, Done AK. Amphetamine poisoning. Effectiveness of chlorpromazine. N Engl J Med 1968; 278:1361-1365.
33. Shoptaw SJ, Kao U, Ling WW. Treatment for amphetamine psychosis. Cochrane Database Syst Rev 2008; 4:CD003026.
34. Richards JR, Albertson TE, Derlet RW, et al. Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug Alcohol Depend 2015; 150:1-13.
35. Verachai V, Rukngan W, Chawanakrasaesin K, et al. Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine. Psychopharmacology 2014; 231:3099-3108.
36. Seddigh R, Keshavarz-Akhlaghi AA, Shariati B. Treating methamphetamine induced resistant psychosis with clozapine. Case Rep Psychiatry 2014; 2014:845145.
37. Haning W, Goebert D. Electrocardiographic abnormalities in methamphetamine abusers. Addiction 2007; 102 (Suppl 1):70-75.
38. Henry BL, Minassian A, Perry W. Effect of methamphetamine dependence on heart rate variability. Addict Biol 2012; 17:648-658.
39. Foster S, Kessel J, Berman ME, Simpson GM. Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. Int Clin Psychopharmacol 1997; 12:175-179.
40. Allen MH, Currier GW, Carpenter D, et al.; Expert Consensus Panel for Behavioral Emergencies 2005. The expert consensus guideline series. Treatment of behavioral emergencies 2005. J Psychiatr Pract 2005; 11 (Suppl 1):5-108.
41. McIver C, McGregor C, Baigent M, et al. Guidelines for the medical management of patients with methamphetamine-induced psychosis. Adelaide, Australia: Government of South Australia; 2006.
42. Ziaaddini H, Roohbakhsh T, Nakhaee N, Ghaffari-Nejad A. Effectiveness of electroconvulsive therapy in persistent methamphetamine psychosis: a pilot study. Addict Health 2015; 7:14-23.